<?xml version="1.0" encoding="UTF-8"?>
<ref id="bjh17168-bib-0012">
 <label>12</label>
 <mixed-citation publication-type="journal" id="bjh17168-cit-0012">
  <string-name>
   <surname>Yong</surname>
   <given-names>K</given-names>
  </string-name>, 
  <string-name>
   <surname>Popat</surname>
   <given-names>R</given-names>
  </string-name>, 
  <string-name>
   <surname>Wilson</surname>
   <given-names>W</given-names>
  </string-name>, 
  <string-name>
   <surname>Pang</surname>
   <given-names>G</given-names>
  </string-name>, 
  <string-name>
   <surname>Jenner</surname>
   <given-names>R</given-names>
  </string-name>, 
  <string-name>
   <surname>De Tute</surname>
   <given-names>RM</given-names>
  </string-name>, et al. 
  <article-title>Efficacy and safety of carfilzomib at 56mg/m2 with cyclophosphamide and dexamethasone (K56Cd) in newly diagnosed multiple myeloma patients followed by ASCT or K56Cd consolidation: initial results of the phase 2 cardamon study</article-title>. 
  <source xml:lang="en">Blood</source>. 
  <year>2019</year>;
  <volume>134</volume>(
  <issue>Supplement 1</issue>):
  <fpage>861</fpage>.
 </mixed-citation>
</ref>
